ArticleBMC cancer2024

Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis.

Yanxiong Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.